- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Congressman Frank Pallone, Jr, Explains the Beginnings of the 21st Century Cures Act
Congressman Frank Pallone, Jr, discusses the origin of the 21st Century Cures Act and the work of the Energy and Commerce Committee to get discussion going about the bill.
The 21st Century Cures Act originated from a small idea in House Energy and Commerce Committee Chairman Fred Upton’s mind that took work from both parties to see success, explained Congressman Frank Pallone, Jr, (D-NJ).
He added that with jurisdiction over healthcare and drug approvals, a health sub committee under the Energy and Commerce Committee traveled the country to arrange hearings and forums to begin discussion of the bill and allow others to join in on the conversation.
“[Chairman Upton and Ranking Member Diana DeGette] felt that, collectively, more needed to be done to cure diseases where we haven’t really made much progress,” Mr Pallone said.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
